CLINICAL_TRIALS
trial_result
· 2019-09-23
Clinical Trial Update: A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis [Phase 1]
Summary
Phase 1 safety study of GSK3039294 in healthy volunteers and amyoidosis patients, terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Amyloidosis | Phase 1 | Status: TERMINATED | Results posted: 2019-09-23